Neuroprotective microRNA-381 Binds to Repressed Early Growth Response 1 (EGR1) and Alleviates Oxidative Stress Injury in Parkinson’s Disease
ACS Chemical Neuroscience · 2023
DOI: 10.1021/acschemneuro.2c00724 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2023. Verfasst von Shaozhen Guo und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medical Sciences, Shanxi University of Chinese Medicine, Jinzhong 030619, P. R. China. Hauptthemen laut MEDLINE: MicroRNAs, Parkinson Disease, Early Growth Response Protein 1. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Shaanxi University of Chinese Medicine, Health Commission of Shanxi Province, Scientific and Technological Innovation Capability Training Projects in Shanxi University of Chinese Medicine.
Abstract (Originalsprache)
As a common and disabling disease of the elderly, the standard therapies of Parkinson's disease (PD) fail to curb the ongoing neurodegeneration, thus calling for newer strategies. This work was conducted to examine the effect of microRNA-381 (miR-381) on oxidative stress injury to dopaminergic neurons in PD in vivo and in vitro. We established an in vivo mouse model of PD using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and an in vitro cell model of PD by treating dopaminergic neuron MN9D cells with 1-methyl-4-phenylpyridinium (MPP+). It was established that miR-381 was poorly expressed in the substantia nigra pars compacta (SNc) of MPTP-lesioned mice. The motor function of MPTP-lesioned mice was evaluated in the presence of ectopic miR-381 expression, and oxidative stress and dopaminergic neuron injury were also characterized. Restoration of miR-381 was demonstrated to diminish oxidative stress and damage in dopaminergic neurons, accompanied by enhanced motor functions. Mechanistically, the putative binding sites of miR-381 were retrieved through the starBase database, and the luciferase activity assay confirmed that it bound to EGR1 and repressed its expression, which then upregulated the expression of PTEN and p53. The neuroprotective effects of miR-381 on the motor function and dopaminergic neuronal damage were counteracted by ectopic EGR1 expression. Together, this study indicates that the binding of miR-381 to EGR1 upregulates PTEN/p53 to alleviate PD, which provides novel insights for a neuroprotective mechanism in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Basic Medical Sciences, Shanxi University of Chinese Medicine, Jinzhong 030619, P. R. China.
ORCID-Profile: Yuwei Zhao
Förderung
- Shaanxi University of Chinese Medicine
- Health Commission of Shanxi Province
- Scientific and Technological Innovation Capability Training Projects in Shanxi University of Chinese Medicine
Zitieren
APA
Guo, S., Gao, Y., & Zhao, Y. (2023). Neuroprotective microRNA-381 Binds to Repressed Early Growth Response 1 (EGR1) and Alleviates Oxidative Stress Injury in Parkinson’s Disease. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.2c00724
Vancouver
Guo S, Gao Y, Zhao Y. Neuroprotective microRNA-381 Binds to Repressed Early Growth Response 1 (EGR1) and Alleviates Oxidative Stress Injury in Parkinson’s Disease. ACS Chemical Neuroscience. 2023. doi:10.1021/acschemneuro.2c00724
BibTeX
@article{Guo2023,
author = {Guo, Shaozhen and Gao, Yuting and Zhao, Yuwei},
title = {Neuroprotective microRNA-381 Binds to Repressed Early Growth Response 1 (EGR1) and Alleviates Oxidative Stress Injury in Parkinson’s Disease},
journal = {ACS Chemical Neuroscience},
year = {2023},
doi = {10.1021/acschemneuro.2c00724}
}
EUVIMED